Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors.
about
Modelling human disease with pluripotent stem cellsAnemia: progress in molecular mechanisms and therapiesVariable behavior of iPSCs derived from CML patients for response to TKI and hematopoietic differentiation.New frontier in regenerative medicine: site-specific gene correction in patient-specific induced pluripotent stem cellsPreventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders.Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells.
P2860
Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Metabolic correction of congen ...... free of reprogramming factors.
@ast
Metabolic correction of congen ...... free of reprogramming factors.
@en
type
label
Metabolic correction of congen ...... free of reprogramming factors.
@ast
Metabolic correction of congen ...... free of reprogramming factors.
@en
prefLabel
Metabolic correction of congen ...... free of reprogramming factors.
@ast
Metabolic correction of congen ...... free of reprogramming factors.
@en
P2093
P2860
P1476
Metabolic correction of congen ...... free of reprogramming factors.
@en
P2093
Aurélie Bedel
Benoît Rousseau
Bruno Cardinaud
Catherine Pain
Cécile Ged
Emmanuel Richard
Eric Lippert
François Moreau-Gaudry
Hubert de Verneuil
Magalie Lalanne
P2860
P304
P356
10.1016/J.AJHG.2012.05.026
P407
P577
2012-07-01T00:00:00Z